Cancer Therapy: Injectable Supramolecular Hydrogels as Delivery Agents of BCL-2 Conversion Gene for the Effective Shrinkage of Therapeutic Resistance Tumors (Adv. Healthcare Mater. 11/2017)
Advanced healthcare materials - United Kingdom
doi 10.1002/adhm.201770053
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley